Claims for Patent: 8,110,553

Summary for Patent: 8,110,553

Title:	Methods and compositions for the treatment of gastrointestinal disorders
Abstract:	The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
Inventor(s):	Currie; Mark G. (Sterling, MA), Mahajan-Miklos; Shalina (Stanford, CA), Milne; G. Todd (Brookline, MA), Norman; Thea (Cambridge, MA)
Assignee:	Ironwood Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:	12/788,979
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,110,553
Patent Claims:	1. A method for increasing intestinal motility in a patient, the method comprising administering to the patient an effective amount of a peptide comprising the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125) or a pharmaceutically acceptable salt thereof. 2. The method of claim 1, wherein the peptide consists of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125) or a pharmaceutically acceptable salt thereof. 3. A method for treating a patient for a gastrointestinal disorder, the method comprising administering to the patient an effective amount of a peptide comprising the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125) or a pharmaceutically acceptable salt thereof. 4. The method of claim 3, wherein the peptide consists of the amino acid sequence Cys Cys Glu Tyr Cys Cys Asn Pro Ala Cys Thr Gly Cys (SEQ ID NO:125) or a pharmaceutically acceptable salt thereof. 5. The method of claim 3, wherein the gastrointestinal disorder is selected from the group consisting of: irritable bowel syndrome, constipation, a gastrointestinal motility disorder, gastroesophageal reflux disease, functional heartburn, dyspepsia, gastroparesis, chronic intestinal pseudo-obstruction and colonic pseudo-obstruction. 6. The method of claim 5, wherein the gastrointestinal disorder is constipation. 7. The method of claim 6, wherein the constipation is chronic constipation, idiopathic constipation, constipation due to post-operative ileus, or constipation caused by opiate use. 8. The method of claim 7, wherein the constipation is chronic constipation. 9. The method of claim 5, wherein the gastrointestinal disorder is irritable bowel syndrome. 10. The method of claim 9, wherein the irritable bowel syndrome is constipation-predominant irritable bowel syndrome. 11. The method of claim 9, wherein the irritable bowel syndrome is alternating irritable bowel syndrome.